Schröder R, Fischer A B, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 10448160 B2, 2024-05-23.
Sørensen M, Johansson L, Rossi M. "Method for the Synthesis of (S)-N-[(2S,4S,5S)-5-(Dibenzylamino)-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
(|AS)-N-[(1S,3S,4S)-4-[Bis(phenylmethyl)amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|A-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
192726-04-8" [P]. European Patent, EP 3936584 A1, 2021-01-16.
发明人冯建国,周伟,韩伟. "A Process for Preparing High-Purity (S)-N-[(2S,4S,5S)-5-(Dibenzylamino)-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
(|AS)-N-[(1S,3S,4S)-4-[Bis(phenylmethyl)amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|A-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
192726-04-8" [P]. 中国发明专利, 专利号 CN 109863925 A, 授权公告日 2021-10-23.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2022, 1892, 7082-7089.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2023, 2151, 7629-7640.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of (S)-N-[(2S,4S,5S)-5-(Dibenzylamino)-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
(|AS)-N-[(1S,3S,4S)-4-[Bis(phenylmethyl)amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|A-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
192726-04-8 Using HRMS and NMR". Environ. Sci. Technol., 2019, 1765, (2), 205-235.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2025, 592, 2247-2265.